Loading…
Thermo Fisher Scientific Inc. is projected to rise to $481.15 by 2027, a +5% move from its current price of $456.21. TMO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $449.84 | $456.13 | $462.51 | -0.02% |
| May 30 | $447.19 | $456.06 | $465.10 | -0.03% |
| May 31 | $445.15 | $455.98 | $467.08 | -0.05% |
| Jun 1 | $443.42 | $455.91 | $468.75 | -0.07% |
| Jun 2 | $441.89 | $455.83 | $470.21 | -0.08% |
| Jun 3 | $440.51 | $455.76 | $471.52 | -0.10% |
| Jun 4 | $439.24 | $455.68 | $472.73 | -0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $439.24 | $455.68 | $472.73 | -0.12% |
| Week 2 | $432.11 | $455.15 | $479.42 | -0.23% |
| Week 3 | $426.59 | $454.62 | $484.49 | -0.35% |
| Week 4 | $421.92 | $454.09 | $488.72 | -0.46% |
| Week 5 | $417.79 | $453.57 | $492.40 | -0.58% |
| Week 6 | $414.05 | $453.04 | $495.70 | -0.70% |
| Week 7 | $410.60 | $452.51 | $498.71 | -0.81% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Thermo Fisher Scientific Inc. is a healthcare company that provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services to customers around the world. It operates across North America, Europe, Asia-Pacific, and internationally.
Thermo Fisher runs through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. The Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services segments provide a range of instruments, kits, services, and clinical laboratory offerings.
Thermo Fisher was founded in 1956 and is headquartered in Waltham, Massachusetts. It is categorized in the Healthcare sector.
Thermo Fisher Scientific Inc. trades as a healthcare stock with a current price of $448.28 and a market capitalization of $166.59B. It ranks 89 in market size.
The price outlook shows the 2026 forecast with an average of $448.28, aligning with the current price, and a longer-run bullish trajectory. By 2030 the forecast shows an average of $575.85, by 2040 an average of $1,110.10, and by 2050 an average of $2,019.48, signaling substantial long-term upside while maintaining uncertainty inherent to forecasts.
Max forecast values imply potential upside across the horizon, with 2030 max $786.71, 2040 max $1,695.21, and 2050 max $3,304.69, reflecting a wide range of possible outcomes under different conditions.
A major floor 16.2% below — a decisive break under it would weaken the trend.
The nearest floor, 3.9% below — buyers have tended to step in here.
The nearest ceiling, 16.5% above — a clean break opens room to run.
A major ceiling 40.2% above — clearing it would confirm fresh momentum.
Key TMO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TMO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $450.77 | Buy | $451.06 | Buy |
| MA 10 | $447.62 | Buy | $451.84 | Buy |
| MA 20 | $457.22 | Sell | $458.84 | Sell |
| MA 50 | $478.76 | Sell | $478.60 | Sell |
| MA 100 | $517.68 | Sell | $499.33 | Sell |
| MA 200 | $526.58 | Sell | $510.37 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.27 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -6.67 | Neutral |
| Williams %R (14) | -50.53 | Info |
| MACD (12,26,9) | 1.27 | Buy |
| ROC (12) | -1.89 | Sell |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 49.47 | Neutral |
| TRIX (15) | -0.35 | Sell |
| Awesome (5,34) | -25.58 | Sell |
| Ultimate (7,14,28) | 65.26 | Neutral |
| Momentum (10) | -3.09 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 451.97 | Buy |
| ADX (14) | 21.11 | Sell |
| ATR (14) | 6.26 | Info |
The 30-day picture is NEUTRAL with RSI(14) at 40. The short-term trend is supported by a SMA50 of $479.36 and a SMA200 of $526.64, indicating near-term resistance above the current price.
Near-term support sits at $438.34, with resistance at $531.67. The thirty-day price range spans from a low of $408.16 to a high of $492.34, illustrating a modest trading band around the present level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $438.34 | $456.21 | $571.56 | 0% | Neutral | |
| $393.06 | $481.15 | $616.49 | +5% | Neutral | |
| $390.40 | $486.61 | $639.78 | +7% | Neutral | |
| $419.26 | $530.50 | $712.00 | +16% | Neutral | |
| $456.99 | $585.94 | $800.32 | +28% | Bullish | |
| $493.79 | $640.77 | $888.86 | +40% | Bullish | |
| $553.07 | $725.73 | $1,020.86 | +59% | Bullish | |
| $564.10 | $747.95 | $1,065.59 | +64% | Bullish | |
| $556.30 | $744.89 | $1,073.81 | +63% | Bullish | |
| $589.48 | $796.75 | $1,161.24 | +75% | Bullish | |
| $795.18 | $1,120.80 | $1,711.36 | +146% | Bullish | |
| $1,354.17 | $2,046.71 | $3,348.97 | +349% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $438.34 | $456.21 | $533.71 | +0.00% |
| June 2026 | $386.20 | $450.53 | $535.76 | -1.25% |
| July 2026 | $382.99 | $449.35 | $539.42 | -0.26% |
| August 2026 | $390.96 | $460.77 | $557.15 | +2.54% |
| September 2026 | $391.83 | $463.51 | $563.79 | +0.59% |
| October 2026 | $384.03 | $455.83 | $557.44 | -1.66% |
| November 2026 | $384.42 | $457.67 | $562.33 | +0.40% |
| December 2026 | $387.90 | $463.12 | $571.56 | +1.19% |
Click any year to see its month-by-month TMO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The TMO price prediction for 2026 points to an average of $456.21 (low $438.34, high $571.56) — a potential gain of 0% on today's $456.21. A consolidation phase looks the most probable path here.
In 2027, TMO is projected to trade between $393.06 and $616.49, averaging $481.15 — a potential gain of +5% from today's $456.21. That is up +5% on the projected 2026 average. Price action looks broadly range-bound.
Thermo Fisher Scientific Inc.'s 2028 outlook centres on $486.61, within a $390.40 to $639.78 range. That is up +1% on the projected 2027 average. That marks a +7% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, TMO could reach as high as $712.00, with a base case around $530.50 and support toward $419.26 — roughly +16% from $456.21. Price action looks broadly range-bound.
Expect TMO to range from $456.99 to $800.32 through 2030. The $585.94 average target implies a +28% move from current prices. That is up +10% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The TMO price prediction for 2031 points to an average of $640.77 (low $493.79, high $888.86) — a potential gain of +40% on today's $456.21. Momentum favours further upside here.
In 2032, TMO is projected to trade between $553.07 and $1,020.86, averaging $725.73 — a potential gain of +59% from today's $456.21. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Thermo Fisher Scientific Inc.'s 2033 outlook centres on $747.95, within a $564.10 to $1,065.59 range. That is up +3% on the projected 2032 average. That marks a +64% change versus current levels. Momentum favours further upside here.
By 2034, TMO could reach as high as $1,073.81, with a base case around $744.89 and support toward $556.30 — roughly +63% from $456.21. Buyers look set to stay in control over this stretch.
Expect TMO to range from $589.48 to $1,161.24 through 2035. The $796.75 average target implies a +75% move from current prices. That is up +7% on the projected 2034 average. Momentum favours further upside here.
The TMO price prediction for 2040 points to an average of $1,120.80 (low $795.18, high $1,711.36) — a potential gain of +146% on today's $456.21. Buyers look set to stay in control over this stretch.
In 2050, TMO is projected to trade between $1,354.17 and $3,348.97, averaging $2,046.71 — a potential gain of +349% from today's $456.21. That is up +83% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in TMO today (≈ 2.191973 TMO) could be worth
$4,486.34
+$3,486.34 (+349%) by 2050 · US Dollar
Based on the average projected TMO price of $2,046.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TMOwould be worth at today's price.
$1,000 invested in TMO on May 27, 2025 (≈ 2.478008 TMO) would be worth
$1,130.49
+$130.49 (+13.0%) today · 1.13× · US Dollar
Based on a TMO entry price of $403.55 vs. today's $456.21.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $451.79 | $1,009.78 | +1.0% |
| 1 month ago | $468.04 | $974.72 | -2.5% |
| 3 months ago | $520.12 | $877.12 | -12.3% |
| 6 months ago | $590.83 | $772.15 | -22.8% |
| 1 year ago | $403.55 | $1,130.49 | +13.0% |
| All time (5.0y) ago | $447.01 | $1,020.58 | +2.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TMO forecast.
Our base-case forecast reaches $910.00 around 2040.
Implied market cap at $910.00: $338.18B
The multi-year forecast shows a shift from NEUTRAL to BULLISH sentiment as time horizons extend. From 2026 through 2029 the average price sits near the current level (2026 avg $448.28; 2027 avg $471.46; 2028 avg $481.55; 2029 avg $522.27) with ROI values ranging from 0% to 16.5%, reflecting uncertainty in the near term.
From 2030 onward, the outlook becomes BULLISH. The 2030 forecast shows an average of $575.85 with a min of $449.04 and a max of $786.71, and an ROI of 28.5%. The 2040 forecast then shows an average of $1,110.10 with a min of $787.51 and a max of $1,695.21, and an ROI of 147.6%.
By 2050, the forecast projects an average of $2,019.48 with a min of $1,336.04 and a max of $3,304.69, and an ROI of 350.5%, with sentiment still BULLISH. These figures illustrate the long-run upside potential along with the higher level of uncertainty that accompanies extended forecasts.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $575.85, a minimum of $449.04, and a maximum of $786.71, with an ROI of 28.5%. The sentiment is BULLISH.
Near-term forecasts (2026–2029) are NEUTRAL with averages near the current price, while the long-run outlook from 2030 onward is BULLISH with substantial upside by 2050 (average $2,019.48 and ROI 350.5%). These are estimates and not guaranteed.
Yes. The forecast maximum reaches $1,006.52 in 2032, with higher maxima in later years (e.g., $1,048.69 in 2033 and $1,060.59 in 2034), indicating possible reach near $1,000 within the forecast horizon.
Current price is $448.28 and market cap is $166.59B.
The thirty-day range is from $408.16 to $492.34.
Thermo Fisher Scientific Inc. Community Discussion
0Share your Thermo Fisher Scientific Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.